Lev Facher
Coverage of Lev Facher in the Nexus archive.
- A neglected issue in pedestrian, biker deaths
The article discusses alcohol consumption as a public health crisis, industry lobbying efforts, and potential policy solutions. It promotes a free newsletter (Morning Rounds) and an event featuring Isa Cueto and Lev Facher.
- STAT+: 10 charts that explain America’s hidden alcohol epidemic
Alcohol-related deaths in the U.S. exceed those from all illicit drugs combined, yet the issue remains under-addressed. Emergency department visits linked to alcohol nearly doubled between 2003 and 2022, with alcohol-related hospitalizations outpacing those from opioids in many states.
- STAT+: Why the WakeMed – Atrium Health hospital merger matters
A hospital system merger in North Carolina has created local controversy but has national relevance. The merger is between WakeMed and Atrium Health. This event may have broader implications for the healthcare industry.
- Why isn’t alcohol seen as a public health emergency?
Alcohol kills more Americans than any other drug, yet it is not seen as a public health emergency. Discussions about substance use epidemics in the U.S. often center around drugs like fentanyl or meth. A new STAT series, 'The Deadliest Drug', aims to explore this contradiction.
- Supreme Court extends mifepristone deadline
The Supreme Court has extended the deadline for mifepristone. The article also mentions a series on alcohol as a public health issue. The series is written by STAT reporters Isabella Cueto and Lev Facher.
- STAT+: Hims takes a $33 million hit from GLP-1 ‘pivot’
Hims takes a $33 million hit from GLP-1 'pivot'. The news is part of STAT's Health Tech newsletter, which covers technology in life sciences. The newsletter also mentions a series on the public health crisis around alcohol.